LENZ Therapeutics, Inc. (LENZ) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$11.22
Day's range
$12.38

LENZ Therapeutics Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
RA CAPITAL MANAGEMENT, L.P. 08/14/2026 4.18 M $23.74 M   0.00% 13.32%
ALPHA WAVE GLOBAL, LP 08/13/2026 3.61 M $20.52 M   0.00% 11.51%
FMR LLC 08/13/2026 3.56 M $20.21 M   -1.08% 11.34%
VERSANT VENTURE MANAGEMENT, LLC 08/12/2026 2.66 M $15.09 M   0.00% 8.47%
BLACKROCK, INC. 08/07/2026 2.29 M $13.02 M   15.95% 7.31%
SQUAREPOINT OPS LLC 08/14/2026 1.75 M $9.92 M   15.97% 5.57%
ABRDN PLC 07/31/2026 1.55 M $8.79 M   33.88% 4.93%
MILLENNIUM MANAGEMENT LLC 08/14/2026 1.51 M $8.57 M   73.54% 4.81%
VANGUARD CAPITAL MANAGEMENT LLC 08/13/2026 1.10 M $6.24 M   5.43% 3.50%
72 INVESTMENT HOLDINGS, LLC 08/14/2026 1.02 M $5.78 M   0.00% 3.24%
BLUE OWL CAPITAL HOLDINGS LP 08/11/2026 756.72 K $4.30 M   49.34% 2.41%
C WORLDWIDE GROUP HOLDING A/S 08/04/2026 700.00 K $3.98 M   0.00% 2.23%
GEODE CAPITAL MANAGEMENT, LLC 08/12/2026 564.66 K $3.21 M   7.64% 1.80%
TREXQUANT INVESTMENT LP 08/14/2026 497.53 K $2.83 M   132.05% 1.59%
MARSHALL WACE, LLP 08/13/2026 493.10 K $2.80 M   207.68% 1.57%
QUBE RESEARCH & TECHNOLOGIES LTD 08/14/2026 482.20 K $2.74 M   100.00% 1.54%
MORGAN STANLEY 08/13/2026 473.00 K $2.69 M   -27.10% 1.51%
PRIMECAP MANAGEMENT CO/CA/ 08/14/2026 472.20 K $2.68 M   0.00% 1.51%
TANG CAPITAL MANAGEMENT LLC 08/14/2026 451.11 K $2.56 M   0.00% 1.44%
ALYESKA INVESTMENT GROUP, L.P. 08/14/2026 438.88 K $2.49 M   -5.31% 1.40%
STATE STREET CORP 08/07/2026 406.67 K $2.31 M   1.11% 1.30%
CITADEL ADVISORS LLC 09/02/2026 363.23 K $2.06 M   100.00% 1.16%
TWO SIGMA INVESTMENTS, LP 08/14/2026 285.58 K $1.62 M   -43.00% 0.91%
ROCK SPRINGS CAPITAL MANAGEMENT LP 08/14/2026 257.46 K $1.46 M   0.00% 0.82%
BANK OF AMERICA CORP /DE/ 08/14/2026 255.41 K $1.45 M   -53.35% 0.81%
DISCOVERY CAPITAL MANAGEMENT, LLC / CT 08/14/2026 241.30 K $1.37 M   0.00% 0.77%
AQR CAPITAL MANAGEMENT LLC 08/14/2026 227.73 K $1.29 M   62.31% 0.73%
JEFFERIES FINANCIAL GROUP INC. 08/17/2026 200.30 K $1.14 M   100.00% 0.64%
VANGUARD PORTFOLIO MANAGEMENT LLC 08/13/2026 193.32 K $1.10 M   26.35% 0.62%
NORTHERN TRUST CORP 08/13/2026 187.14 K $1.06 M   0.82% 0.60%
SCOGGIN MANAGEMENT LP 08/14/2026 175.00 K $994.00 K   40.00% 0.56%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 08/14/2026 172.81 K $981.54 K   15.56% 0.55%
SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. 08/14/2026 172.81 K $981.54 K   100.00% 0.55%
SUSQUEHANNA PORTFOLIO STRATEGIES, LLC 08/14/2026 154.05 K $875.02 K   100.00% 0.49%
GOLDMAN SACHS GROUP INC 08/14/2026 150.66 K $855.74 K   -18.01% 0.48%
VANGUARD FIDUCIARY TRUST CO 08/13/2026 149.44 K $848.82 K   -0.36% 0.48%
OCCUDO QUANTITATIVE STRATEGIES LP 08/13/2026 146.38 K $831.42 K   100.00% 0.47%
QUANTINNO CAPITAL MANAGEMENT LP 08/13/2026 137.72 K $782.22 K   189.03% 0.44%
XTX TOPCO LTD 08/14/2026 130.63 K $741.95 K   -40.90% 0.42%
JUMP FINANCIAL, LLC 08/13/2026 112.18 K $637.19 K   11.96% 0.36%
UBS GROUP AG 08/13/2026 111.83 K $635.17 K   -28.77% 0.36%
CITADEL ADVISORS LLC 09/02/2026 108.80 K $617.98 K   38.78% 0.35%
CITADEL ADVISORS LLC 09/02/2026 108.60 K $616.85 K   44.22% 0.35%
AFFINITY ASSET ADVISORS, LLC 08/13/2026 100.00 K $568.00 K   0.00% 0.32%
WOODLINE PARTNERS LP 08/14/2026 100.00 K $568.00 K   0.00% 0.32%
MANGROVE PARTNERS 08/14/2026 96.75 K $549.53 K   100.00% 0.31%
ROCKEFELLER CAPITAL MANAGEMENT L.P. 08/13/2026 92.35 K $524.55 K   25.92% 0.29%
KBC GROUP NV 08/05/2026 90.43 K $514.00 K   0.00% 0.29%
HSBC HOLDINGS PLC 08/14/2026 79.81 K $448.54 K   264.53% 0.25%
CI PRIVATE WEALTH, LLC 08/27/2026 74.93 K $425.61 K   101.11% 0.24%

LENZ Therapeutics Inc. institutional Ownership - FAQ's

During the previous two years, 184 institutional investors and hedge funds held shares of LENZ Therapeutics Inc.. The most heavily invested institutionals were:

RA CAPITAL MANAGEMENT, L.P.: 4.18 M

Alpha Wave Global, LP: 3.61 M

FMR LLC: 3.56 M

Versant Venture Management, LLC: 2.66 M

BlackRock, Inc.: 2.29 M

Squarepoint Ops LLC: 1.75 M

111.21% of LENZ Therapeutics Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 37.37 M shares in the last 24 months. This purchase volume represents approximately $459.67 M in transactions.